MAPT and Alzheimer disease: Recently miR-218 upregulation was found to contribute to AD progression by enhancing Tau phosphorylation and disrupting mitochondrial respiratory chain through modulating Wnt signaling pathway (Gugliandolo et al., 2020; Wu et al., 2020).